# Effects of a two-week modified ketogenic diet on circulating lipoprotein subclasses, GDF15, and FGF21 in obese adults

**Authors:** Nana Zhang, Na Liu, Guoxia Zhao, Juan Yan, Pinghua Zhang, Xiaomiao Li, Jie Zhou

PMC · DOI: 10.1186/s12967-025-07251-2 · Journal of Translational Medicine · 2025-11-07

## TL;DR

A two-week modified ketogenic diet reduced weight and body fat in obese adults while changing specific blood markers and HDL subclasses.

## Contribution

The study reveals novel metabolic effects of a modified ketogenic diet, including GDF15 elevation and FGF21 reduction, alongside beneficial changes in HDL subclasses.

## Key findings

- A two-week modified ketogenic diet significantly reduced body weight and BMI in obese participants.
- FGF21 levels decreased by 51.91%, while GDF15 levels increased by 5.76%.
- HDL-c subfractions showed significant changes, with larger HDL-c subfractions increasing and smaller ones decreasing.

## Abstract

As key metabolic regulators, the roles of GDF15 and FGF21 in mediating the effects of modified ketogenic diet (MKD) on weight loss and lipoprotein remodeling in obese patients require further investigation.

This study enrolled 30 metabolically healthy obese participants (BMI ≥ 28 kg/m²) for a 2-week MKD intervention. Using a self-controlled pre-post design, we performed measurements including body composition analysis, fasting serum GDF15 and FGF21 levels measurement, and serum lipoprotein subclass quantification at both baseline and post-intervention time points.

Following a 2-week MKD intervention, participants exhibited statistically significant reductions in body weight (96.14 ± 27.23 kg vs. 91.63 ± 26.47 kg; Δ4.8%, P < 0.001) and BMI (33.99 ± 6.08 kg/m2 vs. 32.41 ± 5.95 kg/m2; Δ4.7%, P < 0.001). Body fat parameters significantly improved, with body fat mass (BFM) and visceral fat area (VFA) decreasing by > 5%. Meanwhile, lean mass indices (SMM, SLM, FFM) remained stable (change < 3%). Serum biomarker analysis revealed that GDF15 levels increased significantly by 5.76% (P = 0.0377), whereas FGF21 levels decreased markedly by 51.91% (P = 0.0001). The apolipoprotein B/A1 ratio (t = 5.381, P < 0.001) and the LDL-c/HDL-c ratio (t = 5.095, P < 0.001) increased significantly. Furthermore, larger HDL-c subfractions (H1FC/H2FC) showed an upward trend, while smaller HDL-c subfractions (H3FC/H4FC) exhibited a downward trend. Among these changes, H2FC levels demonstrated the most pronounced elevation (t = 6.119, P < 0.001).

The short-term MKD intervention significantly improved adiposity metrics while elevating GDF15 and reducing FGF21 levels. These rapid metabolic adaptations induced potentially beneficial remodeling of HDL-c subclasses, highlighting novel effects beyond conventional lipid ratios.

ChiCTR, ChiCTR2300071823. Registered 25 May 2023 - Prospective Registered, https://www.chictr.org.cn/bin/project/edit?pid=198176.

## Linked entities

- **Proteins:** GDF15 (growth differentiation factor 15), FGF21 (fibroblast growth factor 21)
- **Diseases:** obesity (MONDO:0011122)

## Full-text entities

- **Genes:** APOB (apolipoprotein B) [NCBI Gene 338] {aka FCHL2, FLDB, LDLCQ4, apoB-100, apoB-48}, GDF15 (growth differentiation factor 15) [NCBI Gene 9518] {aka GDF-15, HG, MIC-1, MIC1, NAG-1, PDF}, COG2 (component of oligomeric golgi complex 2) [NCBI Gene 22796] {aka CDG2Q, LDLC}, FGF21 (fibroblast growth factor 21) [NCBI Gene 26291]
- **Diseases:** weight loss (MESH:D015431), obese (MESH:D009765), adiposity (MESH:D018205)
- **Chemicals:** lipid (MESH:D008055), H2FC (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12595818/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12595818/full.md

## References

4 references — full list in the complete paper: https://tomesphere.com/paper/PMC12595818/full.md

---
Source: https://tomesphere.com/paper/PMC12595818